In this episode of Not So Different, host Skylar Jeremias covers the latest biosimilar developments, including new FDA ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

MONDAY, Feb. 10, 2025 (HealthDay News) -- Surgeons at Massachusetts General Hospital have successfully performed the fourth ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...

The Trump administration's freeze on Health and Human Services data is causing concern among officials in the Lane County ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

The FDA is due to complete its review of an application for the drug's approval as an osteoporosis treatment by July 25. But there are no XenoMouse-derived antibodies in late-stage development at ...

AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...